throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________
`
` AQUESTIVE THERAPEUTICS, INC.,
`Petitioner,
`
`v.
`
`HALE BIOPHARMA VENTURES, LLC,
`Patent Owner.
`____________________
`
`Case IPR2019-00451
`Patent 9,763,876
`____________________
`
`PATENT OWNER UPDATED EXHIBIT LIST
`
`

`

`Exhibit
`No.
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`Description
`
`Epilepsy Fast Facts, CDC (Center for Disease Control and
`Prevetions), CDC 24/7: Saving Lives, Protection People™, Apr. 9,
`2019, pp. 1-2.
`
`Grant Fast Track – Dept. of Health and Human Services re: IND
`112621; NRL-1 (diazepam intranasal solution), Dec. 27, 2016, pp
`1-2.
`
`Howard LeWine, M.D., “Quick Injection Helps Stop Epileptic
`Seizures,” Harvard Health Blog, Feb. 23, 2012; p. 1
`
`“Managing Epilepsy Well Network and Selected Self-Management
`Programs; Putting Collective Wisdom to Work for People with
`Epilepsy,” Prevention Research Centers (PRC), CDC , Nov. 2016,
`pp.1-17
`
`K.M. Fiest, et al., “Prevalence and Incidence of Epilepsy, A
`Systematic Review and Meta-Analysis of International Studies,”
`NEUROLOGY 88, Jan. 17, 2017, pp.296-303
`
`SIGMA Chemical Company Catalog (1988)
`
`E. Bechgaard et al., “Solubilization of Various Benzodiazepines for
`Intranasal Administration, A Pilot Study,” Pharmaceutical
`Development and Technology 2:293-296 (1997)
`
`A. Hussain et al. “Nasal Absorption of Propranolol in Humans,”
`Journal of Pharmaceutical Sciences 69:1240 (1980)
`
`S. Lau and J. Slattery, “Absorption of Diazepam and Lorazepam
`Following Intranasal Administration,” International Journal of
`Pharmaceutics, 54:171-174 (1989)
`
`M. Schols-Hendriks et al., “Absorption of Clonazepam After
`Intranasal and Buccal Administration,” British Journal of Clinical
`Pharmacology 39:449-451 (1995)
`
`2011
`
`Dr. Nicholas Peppas Deposition Transcript, October 24, 2019.
`
`-2-
`
`

`

`2012
`
`2013
`
`2014
`
`2015
`
`2016
`
`2017
`
`2018
`
`2019
`
`2020
`
`2021
`
`2022
`
`Declaration of Dr. Sveinbjorn Gizurarson, Ph.D.
`
`J. Riss et al., “Benzodiazepines in Epilepsy: Pharmacology and
`Pharmacokinetics,” Acta Neurologica Scandinavica 118:69-86
`(2008)
`
`D. Wermeling, U.S. Patent No. 6,610,271, issued August 26, 2003
`
`C. Cole et al., “Community Survey of Carer’s: Individual Epilepsy
`Guidelines (IEG) for Rescue Medication,” Seizure 18:220-224
`(2009)
`
`D. Terry et al., “Acceptance of the Use of Diazepam Rectal Gel in
`School and Day Care Settings,” Journal of Child Neurology
`22:1135-1138 (2007)
`
`Diastat® Label (2005)
`
`“UCB announces NAYZILAM® (midazolam) nasal spray now
`approved by FDA to treat intermittent, stereotypic episodes of
`frequent seizure activity in people living with epilepsy in the U.S.,”
`UCB Press Release,
`https://www.biospace.com/article/releases/ucb-announces-
`nayzilam-midazolam-nasal-spray-now-approved-by-fda-to-treat-
`intermittent-stereotypic-episodes-of-frequent-seizure-activity-in-
`people-living-with-epilepsy-in-the-u-s-/ (2019) (Accessed October
`31, 2019)
`
`J. French and T. Pedley, “Initial Management of Epilepsy,” New
`England Journal of Medicine 359:166-176 (2008)
`
`G. Corbo et al. “Measurement of Nasal Mucociliary Clearance,”
`Archives of Disease in Childhood 64:546-550 (1989)
`
`“How does the nose work? The nasal mucosa,”
`https://www.fitonasal2act.com/how-does-the-nose-work/the-nasal-
`mucosa/ (Accessed November 5, 2019)
`
`N. Mygind, “Nasal Allergy,” 9 (Blackwell Scientific Publications,
`1979)
`
`-3-
`
`

`

`2023
`
`2024
`
`2025
`
`2026
`
`2027
`
`“Neurelis Files New Drug Application With The FDA For
`VALTOCO™ (Diazepam Nasal Spray), An Investigational
`Treatment For Pediatric, Adolescent And Adult Epilepsy Patients,”
`https://www.neurelis.com/neurelis-news/neurelis-files-new-drug-
`application-fda-valtocotm-nasal-spray-investigational-treatment-
`pediatric (2018) (Accessed November 1, 2019)
`
`“Neurelis Receives FDA Orphan Drug Designation for NRL-1 in
`the Treatment of Acute Repetitive Seizures,”
`https://www.neurelis.com/neurelis-news/fda-orphan-drug-
`designation (2015) (Accessed November 1, 2019)
`
`Affidavit of Robert Cleary (Dated November 21, 2019) [SERVED
`BUT NOT FILED]
`
`Affidavit of Ronald Figueroa (Dated November 21, 2019)
`[SERVED BUT NOT FILED]
`
`Transcript of Telephone Conference on Feb. 11, 2020
`
`Date: 13 February 2020
`
`/Lorelei Westin/
`Lorelei Westin, Reg. No. 52,353
`Counsel for Neurelis, Inc.
`
`-4-
`
`

`

`CERTIFICATE OF SERVICE
`I certify that this paper was served electronically on February 13, 2020, to
`
`the following addresses:
`
`Daniel A. Scola, Jr.
`
`dscola@hbiplaw.com
`
`Michael I. Chakansky
`
`mchakansky@hbiplaw.com
`
`James F. Harrington
`
`jharrington@hbiplaw.com
`
`Matthew J. Solow
`
`John T. Gallagher
`
`msolow@hbiplaw.com
`
`jgallagher@hbiplaw.com
`
`Hoffmann & Baron, LLP
`
`876IPR@hbiplaw.com
`
`Date: February 13, 2020
`
`/Robyn Moriarty/
`Robyn Moriarty
`
`-5-
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket